Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania.
paper
Cited
Public
Unavailable
- Authors
- Strakowski, Stephen M; DelBello, Melissa P; Fleck, David E; Adler, Caleb M; Anthenelli, Robert M; Keck, Paul E; Arnold, Lesley M; Amicone, Jennifer
- Year
- 2007
- Journal
- Archives of general psychiatry
- PMID
- 17199055
- DOI
- 10.1001/archpsyc.64.1.57
CONTEXT: Cannabis use disorders commonly co-occur in bipolar disorder; however, the effects of cannabis abuse on outcome have been minimally studied. OBJECTIVE: To identify how the sequence of the onsets of a cannabis use disorder and bipolar disorder is associated with the subsequent course of each condition. DESIGN: Inception cohort. SETTING: Academic medical center. PATIENTS: Patients (N = 144) were studied who met criteria for bipolar I disorder (manic or mixed), were 12 to 45 years old, and had no previous hospitalizations and minimal previous treatment. Patients were followed up for up to 5 years and included 33 in whom the onset of a cannabis use disorder preceded the onset of bipolar disorder (cannabis first), 36 in whom bipolar disorder onset preceded the onset of cannabis abuse (bipolar first), and 75 with bipolar disorder only. MAIN OUTCOME MEASURES: Symptomatic recovery and recurrence of both conditions and percentage of follow-up time with affective and cannabis use disorder symptoms. RESULTS: The cannabis first group exhibited better recovery than the other groups, although when adjusted for potential mediator variables these results did not persist. Cannabis use was associated with more time in affective episodes and with rapid cycling. Most cannabis use disorders remitted immediately after hospitalization, followed by rapid rates of recurrence. CONCLUSIONS: The effects of the sequence of onsets of bipolar and cannabis use disorders were less pronounced than observed in co-occurring alcohol and bipolar disorders. Aggressive drug abuse treatment immediately after a first psychiatric hospitalization might decrease rates of recurrence and new cases of cannabis use disorder in the course of bipolar disorder.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential. | Botsford SL et al. | — | 2025 | → |
| Cannabis and tobacco use in bipolar disorder: Associations with early onset, psychotic symptoms, and relapse risk (2015-2019). | Olivier L et al. | — | 2025 | → |
| Cannabis legalization and cannabis use disorder in United States Veterans Health Administration patients with and without psychiatric disorders, 2005-2022: a repeated cross-sectional study. | Hasin DS et al. | — | 2025 | → |
| Co-Occurring Bipolar and Substance Use Disorders: A Review of Impacts, Biopsychosocial Mechanisms, Assessment, and Treatment. | Sperry SH et al. | — | 2025 | → |
| Sociodemographic influences on substance use in psychosis in an African cohort. | Campbell ML et al. | — | 2025 | → |
| The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors. | Sagar KA et al. | — | 2025 | → |
| A Systematic Review of the Molecular and Cellular Alterations Induced by Cannabis That May Serve as Risk Factors for Bipolar Disorder. | Delgado-Sequera A et al. | — | 2024 | → |
| Cannabis use and mood disorders: a systematic review. | Sorkhou M et al. | — | 2024 | → |
| Clinical, sociodemographic and environmental predicting factors for relapse in bipolar disorder: A systematic review. | Giménez-Palomo A et al. | — | 2024 | → |
| Tobacco, Alcohol, and Drug Use Among Young Adults with Serious Mental Illness. | Ferron JC et al. | — | 2024 | → |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | — | 2023 | → |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder. | Tourjman SV et al. | — | 2023 | → |
| Cannabis use and its relationship with bipolar disorder: A systematic review and meta-analysis. | Maggu G et al. | — | 2023 | → |
| The experience of mood disorder and substance use: An integrative review. | Crowe M et al. | — | 2023 | → |
| Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence. | Kuhns L et al. | — | 2022 | → |
| Contingency Management for Treatment of Cannabis Use Disorder in Co-Occurring Mental Health Disorders: A Systematic Review. | Rodas JD et al. | — | 2022 | → |
| Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder. | Oliva V et al. | — | 2022 | → |
| Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes. | Selloni A et al. | — | 2022 | → |
| Prevalence and association of comorbid substance dependence on the course and outcome of bipolar disorder: Findings from the bipolar disorder course and outcome study from India (BiD-CoIN study). | Grover S et al. | — | 2022 | → |
| Prevalence of Cannabis Use and Factors Related to Hospitalizations in the United States: A Population-Based Study Using National Inpatient Sample Between 2012 and 2018. | Sulley S et al. | — | 2022 | → |
| Psychosocial markers of age at onset in bipolar disorder: a machine learning approach. | Bolton S et al. | — | 2022 | → |
| Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample. | Jegede O et al. | — | 2022 | → |
| A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness. | Kozak K et al. | — | 2021 | → |
| Predictors of conversion from major depressive disorder to bipolar disorder. | Oliveira JP et al. | — | 2021 | → |
| Substance Misuse Trajectories and Risk of Relapse in the Early Course of Bipolar Disorder. | Lagerberg TV et al. | — | 2021 | → |
| Substance use as a risk factor for bipolar disorder: A systematic review. | Lalli M et al. | — | 2021 | → |
| The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review. | Jordan Walter T et al. | — | 2021 | → |
| Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential. | Botsford SL et al. | — | 2020 | → |
| Cannabis Use and the Risk for Psychosis and Affective Disorders. | Sideli L et al. | — | 2020 | → |
| Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants. | Rognli EB et al. | — | 2020 | → |
| Demographic and Clinical Differences Between Bipolar Disorder Patients With and Without Alcohol Use Disorders. | Xia Y et al. | — | 2020 | → |
| The Relationship between Cannabis Use and Cognition in People with Bipolar Disorder: A Systematic Scoping Review | Walter TJ et al. | — | 2020 | — |
| Bipolar disorder and the endocannabinoid system. | Arjmand S et al. | — | 2019 | → |
| Cannabis and mental illness: a review. | Lowe DJE et al. | — | 2019 | → |
| Early Substance Use Cessation Improves Cognition-10 Years Outcome in First-Episode Psychosis Patients. | Weibell MA et al. | — | 2019 | → |
| Gender-related differences in patients with bipolar disorder: a nationwide study. | Buoli M et al. | — | 2019 | → |
| Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis. | Mensen VT et al. | — | 2019 | → |
| Psychotic versus non-psychotic bipolar disorder: Socio-demographic and clinical profiles in an Italian nationwide study. | Altamura AC et al. | — | 2019 | → |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. | Yatham LN et al. | — | 2018 | → |
| Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study. | Feingold D et al. | — | 2018 | → |
| Reducing relapse and suicide in bipolar disorder: practical clinical approaches to identifying risk, reducing harm and engaging service users in planning and delivery of care – the PARADES (Psychoeducation, Anxiety, Relapse, Advance Directive Evaluation and Suicidality) programme | Jones S et al. | — | 2018 | → |
| The Psychiatric Consequences of Cannabinoids. | De Aquino JP et al. | — | 2018 | → |
| Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents. | Lippard ET et al. | — | 2017 | → |
| Cannabis and development of dual diagnoses: A literature review. | Hanna RC et al. | — | 2017 | → |
| Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis. | Foglia E et al. | — | 2017 | → |
| Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study. | Feingold D et al. | — | 2017 | → |
| Commentary on Ostergaard et al. (2017): Evidence of an association between cannabis use and suicide in subjects with bipolar disorder. | Bartoli F | — | 2017 | → |
| Management of comorbid bipolar disorder and substance use disorders. | Salloum IM et al. | — | 2017 | → |
| Review of the efficacy of treatments for bipolar disorder and substance abuse. | Secades-Álvarez A et al. | — | 2017 | → |
| Substance abuse in patients with bipolar disorder: A systematic review and meta-analysis. | Messer T et al. | — | 2017 | → |
| The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis. | Weibell MA et al. | — | 2017 | → |
| Cannabis use disorder is associated with greater illness severity in tobacco smoking patients with bipolar disorder. | Lagerberg TV et al. | — | 2016 | → |
| Cannabis use in first-treatment bipolar I disorder: relations to clinical characteristics. | Kvitland LR et al. | — | 2016 | → |
| Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder. | Weinstock LM et al. | — | 2016 | → |
| Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood. | Sagar KA et al. | — | 2016 | → |
| Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: Systematic review and meta-analysis. | Hunt GE et al. | — | 2016 | → |
| The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay. | Johnson JM et al. | — | 2016 | → |
| The influence of comorbid disorders on the episodicity of bipolar disorder in youth. | Yen S et al. | — | 2016 | → |
| Affective temperaments and concomitant alcohol use disorders in bipolar disorder. | Singh S et al. | — | 2015 | → |
| Cannabis and bipolar disorder: does quitting cannabis use during manic/mixed episode improve clinical/functional outcomes? | Zorrilla I et al. | — | 2015 | → |
| Continued cannabis use at one year follow up is associated with elevated mood and lower global functioning in bipolar I disorder. | Kvitland LR et al. | — | 2015 | → |
| Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder. | Kim SW et al. | — | 2015 | → |
| Risks associated with the non-medicinal use of cannabis. | Hoch E et al. | — | 2015 | → |
| Cannabis and stimulant disorders and readmission 2 years after first-episode psychosis. | Sara GE et al. | — | 2014 | → |
| Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation. | Stone JM et al. | — | 2014 | → |
| Cannabis use and first manic episode. | Bally N et al. | — | 2014 | → |
| Impulsivity predicts time to reach euthymia in adults with bipolar disorder. | Dawson EL et al. | — | 2014 | → |
| Risk and protective factors associated with substance use disorders in adolescents with first-episode mania. | Stephens JR et al. | — | 2014 | → |
| Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample. | Sara GE et al. | — | 2014 | → |
| Thyroglobulin antibodies and risk of readmission at one year in subjects with bipolar disorder. | Barbero JD et al. | — | 2014 | → |
| Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates. | Lev-Ran S et al. | — | 2013 | → |
| Difficulties in emotional regulation and substance use disorders: a controlled family study of bipolar adolescents. | Wilens TE et al. | — | 2013 | → |
| Predictors of first-onset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents. | Goldstein BI et al. | — | 2013 | → |
| Screening for bipolar disorder among outpatients with substance use disorders. | Nallet A et al. | — | 2013 | → |
| Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders. | Carvalho AF et al. | — | 2012 | → |
| Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. | Tambaro S et al. | — | 2012 | → |
| Cigarette smoking and its relationship to mood disorder symptoms and co-occurring alcohol and cannabis use disorders following first hospitalization for bipolar disorder. | Heffner JL et al. | — | 2012 | → |
| Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. | Braga RJ et al. | — | 2012 | → |
| Marijuana impacts mood in bipolar disorder: a pilot study. | Gruber SA et al. | — | 2012 | → |
| Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis. | Rubio G et al. | — | 2012 | → |
| Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. | González-Pinto A et al. | — | 2011 | → |
| Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder. | Jerrell JM et al. | — | 2011 | → |
| Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes. | Najt P et al. | — | 2011 | → |
| Excessive cannabis use is associated with earlier age at onset in bipolar disorder. | Lagerberg TV et al. | — | 2011 | → |
| The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. | Heffner JL et al. | — | 2011 | → |
| Bipolar depression: overview and commentary. | Baldessarini RJ et al. | — | 2010 | → |
| [Cannabis and mood]. | Sanches RF et al. | — | 2010 | → |
| Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study. | González-Pinto A et al. | — | 2010 | → |
| Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). | Ostacher MJ et al. | — | 2010 | → |
| Influence of the serotonin transporter gene polymorphism, cannabis and childhood sexual abuse on phenotype of bipolar disorder: a preliminary study. | De Pradier M et al. | — | 2010 | → |
| Predicting the course and outcome of bipolar disorder: a review. | Treuer T et al. | — | 2010 | → |
| Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis. | Bortolato M et al. | — | 2010 | → |
| Bipolar spectrum-substance use co-occurrence: Behavioral approach system (BAS) sensitivity and impulsiveness as shared personality vulnerabilities. | Alloy LB et al. | — | 2009 | → |
| Cannabis-induced bipolar disorder with psychotic features: a case report. | Khan MA et al. | — | 2009 | → |
| Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. | Mazza M et al. | — | 2009 | → |
| Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients. | Baethge C et al. | — | 2009 | → |
| Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review. | Wilson N et al. | — | 2009 | → |
| Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis. | van Rossum I et al. | — | 2009 | → |
| Substance use disorders as risk factors for psychiatric hospitalization in bipolar disorder. | Hoblyn JC et al. | — | 2009 | → |
| Cannabis and psychiatric disorders: it is not only addiction. | Leweke FM et al. | — | 2008 | → |
| Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder. | Ringen PA et al. | — | 2008 | → |
| Impact of remitted substance use disorders on the future course of bipolar I disorder: findings from a clinical trial. | Gaudiano BA et al. | — | 2008 | → |
| [Induced psychiatric and somatic disorders to cannabis]. | Laqueille X et al. | — | 2008 | → |
| Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities. | McIntyre RS et al. | — | 2008 | → |
| Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. | Baethge C et al. | — | 2008 | → |
| The prevalence and significance of substance use disorders in bipolar type I and II disorder. | Cerullo MA et al. | — | 2007 | → |